COYA
Price
$5.29
Change
+$0.37 (+7.52%)
Updated
Jun 22 closing price
Capitalization
124.32M
56 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$9.57
Change
+$0.41 (+4.48%)
Updated
Jun 22 closing price
Capitalization
1.61B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COYA vs VIR

COYA vs VIR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COYA vs. VIR commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Buy and VIR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (COYA: $5.30 vs. VIR: $9.57)
Brand notoriety: COYA and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 235% vs. VIR: 99%
Market capitalization -- COYA: $124.32M vs. VIR: $1.61B
COYA [@Biotechnology] is valued at $124.32M. VIR’s [@Biotechnology] market capitalization is $1.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than COYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • COYA’s TA Score: 4 bullish, 3 bearish.
  • VIR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both COYA and VIR are a good buy in the short-term.

Price Growth

COYA (@Biotechnology) experienced а +8.38% price change this week, while VIR (@Biotechnology) price change was +11.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.46%. For the same industry, the average monthly price growth was +1.63%, and the average quarterly price growth was +2204.18%.

Reported Earning Dates

COYA is expected to report earnings on Aug 18, 2026.

VIR is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+4.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.61B) has a higher market cap than COYA($124M). VIR YTD gains are higher at: 58.706 vs. COYA (-8.621). COYA has higher annual earnings (EBITDA): -22.5M vs. VIR (-460.62M). VIR has more cash in the bank: 476M vs. COYA (50.7M). VIR has higher revenues than COYA: VIR (64.7M) vs COYA (7.94M).
COYAVIRCOYA / VIR
Capitalization124M1.61B8%
EBITDA-22.5M-460.62M5%
Gain YTD-8.62158.706-15%
P/E RatioN/AN/A-
Revenue7.94M64.7M12%
Total Cash50.7M476M11%
Total DebtN/A95.6M-
FUNDAMENTALS RATINGS
VIR: Fundamental Ratings
VIR
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
33
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYAVIR
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
86%
Bullish Trend 12 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
Bearish Trend 16 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDMA44.040.50
+1.14%
Gadsden Dynamic Multi-Asset ETF
IYZ41.860.26
+0.63%
iShares US Telecommunications ETF
NVYY13.140.05
+0.34%
GraniteShares YieldBOOST NVDA ETF
RGYY8.240.01
+0.12%
GraniteShares YieldBOOST RGTI ETF
SQLV49.57-0.30
-0.60%
Royce Quant Small-Cap Quality Value ETF

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+7.72%
KNSA - COYA
42%
Loosely correlated
+3.67%
GANX - COYA
41%
Loosely correlated
-1.33%
VIR - COYA
36%
Loosely correlated
+4.48%
RCKT - COYA
34%
Loosely correlated
+3.13%
ACET - COYA
33%
Loosely correlated
+1.60%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+4.48%
BEAM - VIR
55%
Loosely correlated
+4.07%
PCVX - VIR
53%
Loosely correlated
+1.30%
DNLI - VIR
52%
Loosely correlated
+3.17%
XNCR - VIR
50%
Loosely correlated
+10.84%
RCUS - VIR
50%
Loosely correlated
+12.01%
More